CBS 2019
CBSMD教育中心
English

ASCVD Prevention

科研文章

荐读文献

From Detecting the Vulnerable Plaque to Managing the Vulnerable Patient How Far We Have Come, How Far We Have Yet to Go in Atherosclerosis Research Can Biomarkers of Myocardial Injury Provide Complementary Information to Coronary Imaging? From Subclinical Atherosclerosis to Plaque Progression and Acute Coronary Events CD163+ macrophages promote angiogenesis and vascular permeability accompanied by inflammation in atherosclerosis Association of Sustained Blood Pressure Control with Multimorbidity Progression Among Older Adults Effect of Evolocumab on Complex Coronary Disease Requiring Revascularization Adenosine and adenosine receptor-mediated action in coronary microcirculation Polygenic Scores to Assess Atherosclerotic Cardiovascular Disease Risk: Clinical Perspectives and Basic Implications Evolocumab for Early Reduction of LDL Cholesterol Levels in Patients With Acute Coronary Syndromes (EVOPACS)

Guideline10 Jan 2022

JOURNAL:Circulation. Article Link

Comprehensive Management of Cardiovascular Risk Factors for Adults With Type 2 Diabetes: A Scientific Statement From the American Heart Association

JJ Joseph, and on behalf of the American Heart Association Diabetes Committee of the Council on Lifestyle and Cardiometabolic Health; Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Clinical Cardiology; and Council on Hypertension Keywords: T2DM; CVD prevention

Full Text PDF